Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study.
Alzheimer’s disease
Dementia
Pain
Tramadol
Vascular dementia
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 Oct 2024
11 Oct 2024
Historique:
received:
03
03
2024
accepted:
30
09
2024
medline:
12
10
2024
pubmed:
12
10
2024
entrez:
11
10
2024
Statut:
epublish
Résumé
We aimed to assess the association of tramadol use with the risk of dementia. This population-based retrospective cohort study using the Korean National Health Insurance Service database included a total of 1,865,827 older adult patients aged 60 years or older with common musculoskeletal pain between January 1, 2003, and December 31, 2007. Individuals who were newly dispensed tramadol (N = 41,963) were identified and propensity score-matched with those who were not (N = 41,963). Over a maximum of 14-year follow-up, the incidence rates (events per 1000 person-years) of all-cause dementia were 6.1 for nonusers, 6.2 for those with cumulative tramadol use of 1-14 days, 7.7 for those with 15-90 days of use, and 8.0 for those with > 90 days of use. Longer cumulative duration of tramadol use was associated with an increased risk of all-cause dementia compared with nonuse (1 to 14 days: aHR 1.06, 95% CI 0.96-1.17; 15 to 90 days: aHR 1.14, 95% CI 1.10-1.35; and more than 90 days: aHR 1.18, 95% CI 1.00-1.39; test for trend: P < 0.001). The results showed a similar pattern for Alzheimer's disease and were robust across subgroup and sensitivity analyses, but not for vascular dementia. This study found that exposure to tramadol was associated with an increased risk of dementia. Taking this potential risk into consideration, clinicians should carefully weigh potential benefits and risks when prescribing tramadol to older adults with musculoskeletal pain.
Identifiants
pubmed: 39394390
doi: 10.1038/s41598-024-74817-3
pii: 10.1038/s41598-024-74817-3
doi:
Substances chimiques
Tramadol
39J1LGJ30J
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
23850Informations de copyright
© 2024. The Author(s).
Références
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 376, e068208 (2022).
Lin, I. et al. What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review. Br. J. Sports Med. 54(2), 79–86 (2020).
pubmed: 30826805
doi: 10.1136/bjsports-2018-099878
Dowell, D., Haegerich, T. M. & Chou, R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm. Rep. 65(1), 1–49 (2016).
pubmed: 26987082
doi: 10.15585/mmwr.rr6501e1
Dowell, D., Haegerich, T. & Chou, R. No shortcuts to safer opioid prescribing. N. Engl. J. Med. 380(24), 2285–2287 (2019).
pubmed: 31018066
doi: 10.1056/NEJMp1904190
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T. & Chou, R. CDC Clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm. Rep. 71(3), 1–95 (2022).
pubmed: 36327391
doi: 10.15585/mmwr.rr7103a1
Alsultan, M. M. & Guo, J. J. Utilization, spending, and price of opioid medications in the US Medicaid programs between 1991 and 2019. Am. Health Drug Benefits 15(1), 31–37 (2022).
pubmed: 35586617
Jani, M., Birlie Yimer, B., Sheppard, T., Lunt, M. & Dixon, W. G. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. PLoS Med. 17(10), e1003270 (2020).
pubmed: 33057368
doi: 10.1371/journal.pmed.1003270
Cho, N. R. et al. Trends in opioid prescribing practices in South Korea, 2009–2019: Are we safe from an opioid epidemic?. PLoS ONE 16(5), e0250972 (2021).
pubmed: 33979378
doi: 10.1371/journal.pone.0250972
Miotto, K. et al. Trends in tramadol: Pharmacology, metabolism, and misuse. Anesth. Analg. 124(1), 44–51 (2017).
pubmed: 27861439
doi: 10.1213/ANE.0000000000001683
Mullins, P. M. et al. Tramadol use in United States emergency departments 2007–2018. J. Emerg. Med. 62(5), 668–674 (2022).
pubmed: 35370038
doi: 10.1016/j.jemermed.2022.01.004
Kim, K., Lee, H. & Shin, J. Y. Explosive increase in tramadol use in Korea 2003–2013: Analysis of patient trends based on the Korea national health insurance database. J. Psychoact. Drugs 52(2), 153–161 (2020).
doi: 10.1080/02791072.2019.1612125
Toupin April, K. et al. Tramadol for osteoarthritis. Cochrane Database Syst. Rev. (2019).
doi: 10.1002/14651858.CD005522.pub3
pubmed: 31132298
Wewege, M. A. et al. Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis. BMJ 380, e072962 (2023).
pubmed: 36948512
doi: 10.1136/bmj-2022-072962
Xie, J. et al. Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes. JAMA 326(15), 1504–1515 (2021).
pubmed: 34665205
doi: 10.1001/jama.2021.15255
Morrow, R. L. et al. Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits. BMJ Open 9(3), e026705 (2019).
pubmed: 30872555
doi: 10.1136/bmjopen-2018-026705
Fournier, J. P., Azoulay, L., Yin, H., Montastruc, J. L. & Suissa, S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern. Med. 175(2), 186–193 (2015).
pubmed: 25485799
doi: 10.1001/jamainternmed.2014.6512
Wei, J. et al. Association of tramadol with risk of myocardial infarction among patients with osteoarthritis. Osteoarthr. Cartil. 28(2), 137–145 (2020).
doi: 10.1016/j.joca.2019.10.001
Hedenmalm, K. et al. Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016. Eur. J. Clin. Pharmacol. 75, 707–716 (2019).
pubmed: 30675632
doi: 10.1007/s00228-018-02622-9
Musich, S. et al. Safety events associated with tramadol use among older adults with osteoarthritis. Popul. Health Manag. 24(1), 122–132 (2021).
pubmed: 32119805
doi: 10.1089/pop.2019.0220
Neelamegam, M. et al. The effect of opioids on the cognitive function of older adults: results from the personality and total health through life study. Age Ageing 50(5), 1699–1708 (2021).
pubmed: 33755047
doi: 10.1093/ageing/afab048
Dublin, S. et al. Prescription opioids and risk of dementia or cognitive decline: A prospective cohort study. J. Am. Geriatr. Soc. 63(8), 1519–1526 (2015).
pubmed: 26289681
doi: 10.1111/jgs.13562
Levine, S. Z., Rotstein, A., Goldberg, Y., Reichenberg, A. & Kodesh, A. Opioid exposure and the risk of dementia: A national cohort study. Am. J. Geriatr. Psychiatry 31(5), 315–323 (2023).
pubmed: 35718587
doi: 10.1016/j.jagp.2022.05.013
Sun, M., Chen, W. M., Wu, S. Y. & Zhang, J. Long-term opioid use and dementia risk in patients with chronic pain. J. Am. Med. Dir. Assoc. 24(9), 1420-1426.e1422 (2023).
pubmed: 37545051
doi: 10.1016/j.jamda.2023.06.035
Raj, K., Chawla, P. & Singh, S. Neurobehavioral consequences associated with long term tramadol utilization and pathological mechanisms. CNS Neurol. Disord. Drug Targets 18(10), 758–768 (2019).
pubmed: 31721720
doi: 10.2174/1871527318666191112124435
Hosseini-Sharifabad, A., Rabbani, M., Sharifzadeh, M. & Bagheri, N. Acute and chronic tramadol administration impair spatial memory in rat. Res. Pharm. Sci. 11(1), 49–57 (2016).
pubmed: 27051432
Khatmi, A. et al. Combined molecular, structural and memory data unravel the destructive effect of tramadol on hippocampus. Neurosci. Lett. 771, 136418 (2022).
pubmed: 34954113
doi: 10.1016/j.neulet.2021.136418
Hussein, O. A., Abdel Mola, A. F. & Rateb, A. Tramadol administration induced hippocampal cells apoptosis, astrogliosis, and microgliosis in juvenile and adult male mice, histological and immunohistochemical study. Ultrastruct. Pathol. 44(1), 81–102 (2020).
pubmed: 31924115
doi: 10.1080/01913123.2019.1711480
Taipale, H. et al. Is Alzheimer’s disease associated with previous opioid use?. Pain Med. 19(11), 2115–2121 (2018).
pubmed: 29025166
doi: 10.1093/pm/pnx210
Anekar, A. A., Hendrix, J. M. & Cascella, M. WHO analgesic ladder. In StatPearls (eds Anekar, A. A. et al.) (StatPearls Publishing, 2023).
Kostev, K., Bohlken, J. & Jacob, L. Analysis of the effects of selective serotonin (and noradrenaline) reuptake inhibitors on the risk of dementia in patients with depression. J. Alzheimers Dis. 69(2), 577–583 (2019).
pubmed: 31104029
doi: 10.3233/JAD-190239
Wang, G. H. et al. Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study. BMC Geriatr. 23, 825 (2023).
pubmed: 38066473
doi: 10.1186/s12877-023-04475-z
Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 396, 413–446 (2020).
pubmed: 32738937
doi: 10.1016/S0140-6736(20)30367-6
Aghajanpour, F. et al. Tramadol: a potential neurotoxic agent affecting prefrontal cortices in adult male rats and PC-12 cell line. Neurotox. Res. 38(2), 385–397 (2020).
pubmed: 32378056
doi: 10.1007/s12640-020-00214-z
Ezi, S. et al. Chronic exposure to tramadol induces neurodegeneration in the cerebellum of adult male rats. Neurotox. Res. 39, 1134–1147 (2021).
pubmed: 33818692
doi: 10.1007/s12640-021-00354-w
Soltani, R. et al. Tramadol exposure upregulated apoptosis, inflammation and autophagy in PC12 cells and rat’s striatum: An in vitro- in vivo approach. J. Chem. Neuroanat. 109, 101820 (2020).
pubmed: 32526246
doi: 10.1016/j.jchemneu.2020.101820
Swart, L. M., van der Zanden, V., Spies, P. E., de Rooij, S. E. & van Munster, B. C. The comparative risk of delirium with different opioids: A systematic review. Drugs Aging 34(6), 437–443 (2017).
pubmed: 28405945
doi: 10.1007/s40266-017-0455-9
Brouquet, A. et al. Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann. Surg. 251(4), 759–765 (2010).
pubmed: 20224380
doi: 10.1097/SLA.0b013e3181c1cfc9
Fong, T. G. & Inouye, S. K. The inter-relationship between delirium and dementia: the importance of delirium prevention. Nat. Rev. Neurol. 18(10), 579–596 (2022).
pubmed: 36028563
doi: 10.1038/s41582-022-00698-7
Gibbison, B., Bailey, C. R. & Klein, A. A. Tramadol - the marmite(™) drug. Anaesthesia 70(2), 125–130 (2015).
pubmed: 25491015
doi: 10.1111/anae.12972
Iadecola, C. et al. The neurovasculome: Key roles in brain health and cognitive impairment: A scientific statement from the American heart association/American stroke association. Stroke 54(6), e251–e271 (2023).
pubmed: 37009740
doi: 10.1161/STR.0000000000000431
Whitlock, E. L. et al. Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern. Med. 177(8), 1146–1153 (2017).
pubmed: 28586818
doi: 10.1001/jamainternmed.2017.1622
Rouch, I., Edjolo, A., Laurent, B., Dartigues, J. F. & Amieva, H. Chronic pain and long-term dementia risk in older adults: Results from a 24-year longitudinal study. Int. J. Geriatr. Psychiatry (2022).
doi: 10.1002/gps.5713
pubmed: 35434855
Kim, H. K., Song, S. O., Noh, J., Jeong, I. K. & Lee, B. W. Data configuration and publication trends for the Korean national health insurance and health insurance review & assessment database. Diabetes Metab. J. 44(5), 671–678 (2020).
pubmed: 33115211
doi: 10.4093/dmj.2020.0207
Seong, S. C. et al. Cohort profile: the national health insurance service-national health screening cohort (NHIS-HEALS) in Korea. BMJ Open 7(9), e016640 (2017).
pubmed: 28947447
doi: 10.1136/bmjopen-2017-016640
Austin, P. C. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm. Stat. 10(2), 150–161 (2011).
pubmed: 20925139
doi: 10.1002/pst.433
Jeong, S. M. et al. Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons. Alzheimers Res. Ther. 9, 94 (2017).
pubmed: 29212527
doi: 10.1186/s13195-017-0322-2
Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94(446), 496–509 (1999).
doi: 10.1080/01621459.1999.10474144
Delgado-Rodríguez M, Llorca J. Bias. J. Epidemiol. Community Health 58(8), 635–641. (2004)